ES2551157T3 - Uso de glucosilglicerol - Google Patents

Uso de glucosilglicerol Download PDF

Info

Publication number
ES2551157T3
ES2551157T3 ES09778036.5T ES09778036T ES2551157T3 ES 2551157 T3 ES2551157 T3 ES 2551157T3 ES 09778036 T ES09778036 T ES 09778036T ES 2551157 T3 ES2551157 T3 ES 2551157T3
Authority
ES
Spain
Prior art keywords
substances
glucosylglycerol
proteins
allergens
toxins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES09778036.5T
Other languages
English (en)
Inventor
Julia Klein
Gerhard Stumm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bitop AG
Original Assignee
Bitop AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bitop AG filed Critical Bitop AG
Application granted granted Critical
Publication of ES2551157T3 publication Critical patent/ES2551157T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists

Abstract

Uso de glucosilglicerol para la preparación de un producto para la protección de la piel y/o la mucosa humanas frente a compuestos de oxígeno reactivos, radicales libres, productos químicos, toxinas, alérgenos, sustancias desnaturalizantes, sustancias que se unen al ADN, sustancias que dañan a las proteínas, sustancias que desactivan proteínas o polvo en suspensión mediante aumento de la expresión de enzimas protectoras de células.

Description

imagen1
imagen2
imagen3
imagen4

Claims (1)

  1. imagen1
ES09778036.5T 2008-08-22 2009-08-21 Uso de glucosilglicerol Active ES2551157T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102008039231 2008-08-22
DE102008039231A DE102008039231A1 (de) 2008-08-22 2008-08-22 Verwendung von Glucosylglycerol
PCT/EP2009/006083 WO2010020424A2 (de) 2008-08-22 2009-08-21 Verwendung von glucosylglycerol

Publications (1)

Publication Number Publication Date
ES2551157T3 true ES2551157T3 (es) 2015-11-16

Family

ID=41566715

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09778036.5T Active ES2551157T3 (es) 2008-08-22 2009-08-21 Uso de glucosilglicerol

Country Status (7)

Country Link
US (2) US9867767B2 (es)
EP (1) EP2328545B1 (es)
JP (1) JP2012500781A (es)
DE (1) DE102008039231A1 (es)
ES (1) ES2551157T3 (es)
PL (1) PL2328545T3 (es)
WO (1) WO2010020424A2 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008537734A (ja) * 2005-03-12 2008-09-25 ビトップ アクツィエンゲゼルシャフト フュール ビオテヒニシェ オプティミールング 経口で用いられる適合溶質を含む薬剤
DE102008039231A1 (de) 2008-08-22 2010-02-25 Bitop Ag Verwendung von Glucosylglycerol
WO2013077433A1 (ja) 2011-11-24 2013-05-30 東洋精糖株式会社 角結膜保護剤または角結膜障害抑制剤
JP6061474B2 (ja) * 2012-02-17 2017-01-18 東洋精糖株式会社 ラジカルによる蛋白質の変性および／または分解の抑制方法
DE102012013482A1 (de) * 2012-07-09 2014-01-09 Bitop Ag Zusammensetzung zur Förderung der Wiederherstellung von verletztem Körpergewebe
JP2014058472A (ja) * 2012-09-18 2014-04-03 Toyo Seito Kk 皮膚老化防止用化粧料
FR2997853B1 (fr) * 2012-11-09 2016-11-04 Oreal Utilisation d'extrait de myrothamnus flabellifolia et de rhamnose pour lutter contre les signes du vieillissement cutane.
JP6077899B2 (ja) * 2013-03-21 2017-02-08 サッポロビール株式会社 アセトアルデヒドデヒドロゲナーゼ阻害剤
US10543158B2 (en) 2017-04-17 2020-01-28 W Skincare, LLC Autophagy activating complex, compositions and methods
CN109998937B (zh) * 2019-03-22 2021-06-29 南京工业大学 含有甘油葡糖苷(αGG)的系列化妆品及其制备方法
JP2020158449A (ja) * 2019-03-27 2020-10-01 東洋精糖株式会社 グルタチオンレダクターゼ発現促進剤、抗酸化能改善剤
WO2020196484A1 (ja) * 2019-03-28 2020-10-01 東洋精糖株式会社 皮膚バリア機能促進剤

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261995A (en) 1979-08-31 1981-04-14 Syntex (U.S.A.) Inc. 4-Phenyl-and 5-phenyl-1,4,5,6-tetrahydropyrimidine derivatives
EP0053754B1 (de) 1980-12-06 1986-04-23 Reichert, Dietrich, Dr. med. Mittel zur Bekämpfung des Schnarchens und Verfahren zu dessen Anwendung
DE3635522A1 (de) 1986-10-18 1988-04-28 Euro Celtique Sa Pharmazeutische zusammensetzung
SE467340B (sv) 1990-07-04 1992-07-06 Perstorp Ab Anvaendning av inositolmonofosfat foer framstaellning av ett laekemedel effektivt som en neuropeptid y-(npy-)antagonist
FR2674434B1 (fr) 1991-03-27 1993-06-18 Nativelle Sa Ets Nouvelle composition pharmaceutique a base de taurine pour l'administration par inhalation.
IL100810A (en) 1992-01-30 1996-12-05 Yeda Res & Dev Pharmaceutical preparations including 2 - methyl - carboxy - 5 - hydroxy - tetrahydropyrimidine and / or 2 - methyl - 4 - carboxy - tetrahydropyrimidine, plywood methods
IL101056A (en) 1992-02-24 1997-03-18 Res & Dev Co Ltd Composition for nasal treatment
US5834473A (en) 1993-04-29 1998-11-10 Cultor, Ltd. Method for treating coccidiosis
DE4342560A1 (de) 1993-12-14 1995-06-22 Marbert Gmbh Ectoin und Ectoinderivate als Feuchtigkeitsspender in Kosmetikprodukten
DE19540749A1 (de) 1995-11-02 1997-05-07 Beiersdorf Ag Kosmetische Zubereitungen mit einem wirksamen Gehalt an Glycosylglyceriden
US5880098A (en) * 1996-04-12 1999-03-09 Pharmacia & Upjohn Aktiebolag Therapeutic treatment
PT101887A (pt) 1996-06-28 1998-01-30 Inst De Biolog Ex E Tecnologic Utilizacao de 2-0- -manosilglicerato para termoestabilizacao, osmoproteccao e proteccao contra a desidratacao de enzimas, outros componenetes celulares e celulas
DE19634021A1 (de) * 1996-08-23 1998-02-26 Beiersdorf Ag Antiadhäsive Glycoglycerolipide
US20010056068A1 (en) 1998-03-04 2001-12-27 Kristof Chwalisz Method of treatment and prevention of nitric oxide deficiency-related disorders with citrulline and citrulline derivatives
WO2000007560A1 (de) 1998-08-01 2000-02-17 Merck Patent Gmbh Verwendung von ectoin oder ectoin-derivaten in kosmetischen formulierungen
US6080401A (en) 1998-11-19 2000-06-27 Reddy; Malireddy S. Herbal and pharmaceutical drugs enhanced with probiotics
JP2002532520A (ja) 1998-12-22 2002-10-02 ザ・ユニヴァーシティ・オヴ・ノース・キャロライナ・アト・チャペル・ヒル 気道病治療および気道用薬剤送達のための化合物および方法
CA2376894C (en) 1999-06-12 2009-10-20 Bitop Gmbh Pharmaceutical composition comprising a protein and an ectoine
DE50104611D1 (de) 2000-04-12 2004-12-30 Bitop Ag Verwendung von kompatiblen soluten als substanzen mit radikalfangenden eigenschaften
US6716819B2 (en) 2000-05-19 2004-04-06 University Of Iowa Research Foundation Use of xylitol to reduce ionic strength and activate endogenous antimicrobials for prevention and treatment of infections
ES2336545T3 (es) 2000-08-18 2010-04-14 Bitop Gesellschaft Fur Biotechnische Optimierung Mbh Empleo de fosfatos de alcoholes disacaricos para la proteccion de las celulas cutaneas humanas contra la irradiacion uv y/o ir.
US7048910B2 (en) 2000-09-07 2006-05-23 Merck Patent Gmbh Use of ectoine or ectoine derivatives for oral care
US20020151541A1 (en) 2000-10-31 2002-10-17 Michel Pairet Pharmaceutical compositions containing tiotropium salts and antihistamines and their use
FR2819411B1 (fr) 2001-01-18 2003-02-21 Oreal Composition cosmetique irisee et ses utilisations
FR2826011B1 (fr) 2001-06-14 2004-12-10 Oreal Nouveaux derives de la 7-oxo-dhea et utilisation cosmetique
DE10133202A1 (de) 2001-07-07 2003-01-16 Beiersdorf Ag Osmolyte enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
FR2832156B1 (fr) 2001-11-15 2004-05-28 Oreal Preparation de composes de type betainates de polysaccharides, composes obtenus, leur utilisation et les compositions les comprenant
US6485711B1 (en) 2002-03-21 2002-11-26 Michael J. Olmstead Organic toothpaste containing saponin
DE10240923A1 (de) 2002-09-02 2004-03-04 Merck Patent Gmbh Flavonoid-Derivate zur Ekzem-Behandlung
US7714011B2 (en) 2002-09-13 2010-05-11 Zicam, Llc Compositions to reduce congestion and methods for application thereof to the nasal membrane
JP2004331583A (ja) * 2003-05-08 2004-11-25 Noevir Co Ltd 皮膚洗浄料
JP4039567B2 (ja) * 2003-05-08 2008-01-30 株式会社ノエビア 水性化粧料
JP4307148B2 (ja) * 2003-05-08 2009-08-05 株式会社ノエビア 細胞賦活剤
DE10330243A1 (de) 2003-07-03 2005-01-20 bitop Aktiengesellschaft für biotechnische Optimierung Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von Arzneimitteln zur äusserlichen Behandlung der Neurodermitis
DE10330768A1 (de) 2003-07-07 2005-02-24 bitop Aktiengesellschaft für biotechnische Optimierung Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von inhalierbaren Arzneimitteln zur Prophylaxe und Behandlung pulmonaler und kardiovaskulärer Erkrankungen, sowie eines Osmolyte als Wirkstoffbestandteil enthaltende Inhalationsvorrichtung
EP1694293A2 (en) 2003-11-29 2006-08-30 Passion For Life Healthcare Limited Composition and delivery system comprising multilayered microparticles
DE102004049062A1 (de) 2004-03-30 2005-10-13 bitop Aktiengesellschaft für biotechnische Optimierung Topische Zubereitung zur Anwendung auf der Haut enthaltend natürliches Öl der Nachtkerze (Oenothera biennis) (=Oleum Oenothera) und Osmolyte aus extremophilen Mikroorganismen
CA2598666A1 (en) 2005-02-23 2006-08-31 Alza Corporation Intranasal administration of active agents to the central nervous system
JP2008537734A (ja) 2005-03-12 2008-09-25 ビトップ アクツィエンゲゼルシャフト フュール ビオテヒニシェ オプティミールング 経口で用いられる適合溶質を含む薬剤
DE102005023639A1 (de) * 2005-05-19 2006-11-23 Beiersdorf Ag Wirkstoffkombinationen aus Glucosylglyceriden, oberflächenaktiven Glucosederivaten und Oligoglycerinderivaten
DE102005023636A1 (de) * 2005-05-19 2006-11-23 Beiersdorf Ag Wirkstoffkombinationen aus Glucosylglyceriden und Kreatin und / oder Kreatinin
DE102005023640A1 (de) * 2005-05-19 2006-11-23 Beiersdorf Ag Wirkstoffkombinationen aus Glucosylglyceriden und einem oder mehreren partiell neutralisierten Ester von Monoglyceriden und / oder Diglyceriden gesättigter Fettsäuren mit Zitronensäure
US20090130223A1 (en) * 2006-04-27 2009-05-21 Ute Breitenbach Cosmetic preparation with aquaporin stimulators and the use thereof
JP2008024622A (ja) * 2006-07-20 2008-02-07 Noevir Co Ltd Ｉｖ型コラーゲン産生促進剤及び基底膜強化剤
AT504347B8 (de) * 2006-09-21 2008-09-15 Univ Graz Tech Verfahren zur herstellung von glucosederivaten
DE102006055041A1 (de) * 2006-11-17 2008-05-21 Beiersdorf Ag Kosmetische Formulierung mit Glucosylglyceriden und kationischen Emulgatoren
DE102006056766A1 (de) 2006-12-01 2008-06-05 Bitop Ag Verwendung von kompatiblen Soluten
DE102007040615A1 (de) 2007-08-27 2009-03-05 Bitop Ag Osmolyte zur Behandlung von allergisch oder viral bedingten Atemwegserkrankungen
DE102007052380A1 (de) * 2007-10-31 2009-05-07 Bitop Ag Osmolythaltige Zubereitungen zur Anwendung bei trockenen Schleimhäuten
DE102008039231A1 (de) 2008-08-22 2010-02-25 Bitop Ag Verwendung von Glucosylglycerol
DE102008053549A1 (de) 2008-10-28 2010-04-29 Bitop Ag Glucosylglycerol enthaltende Zusammensetzung
DE102011113059A1 (de) 2011-09-09 2013-03-14 Bitop Ag Therapeutische Anwendungen von Ectoin

Also Published As

Publication number Publication date
WO2010020424A2 (de) 2010-02-25
US20110207681A1 (en) 2011-08-25
WO2010020424A3 (de) 2010-04-29
JP2012500781A (ja) 2012-01-12
DE102008039231A1 (de) 2010-02-25
US9867767B2 (en) 2018-01-16
US20180015017A1 (en) 2018-01-18
PL2328545T3 (pl) 2016-04-29
EP2328545A2 (de) 2011-06-08
EP2328545B1 (de) 2015-08-05

Similar Documents

Publication Publication Date Title
ES2551157T3 (es) Uso de glucosilglicerol
AR106702A2 (es) Uso de un anticuerpo antagonista anti-ngf para la preparación de un medicamento
ES2534304T3 (es) Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN
GT200800065A (es) Métodos y composiciones para modular la hemostasia
FI20060729A0 (fi) Ihon- tai karvanhoitokoostumus tai sen valmistuksessa käytetty puolivalmiste
DE502007002815D1 (de) Polihexanidhaltige Liposomen
BRPI0718382A2 (pt) Composições, uso das mesmas e processo para o combate de pragas animais ou fungos fitopatogênicos
CL2007002376A1 (es) Compuestos derivados de pirrol sustituido; proceso de preparacion; composicion farmaceutica; y uso en enfermedades bacterianas.
BRPI0812766A2 (pt) 4-cloro-4-alcóxi-1,1,1-triflúor-2-butanonas, preparação das mesmas e uso das mesmas no preparo de 4-alcóxi-1,1,1-triflúor-3-buten-2-onas
CL2008001573A1 (es) Combinaciones fungicidas que contienen n-[2-(1,3-dimetilbutil)fenil]-5-fluoro-1,3-dimetil-1h-pirazol-4-carboxamida, al menos una acilalanina y al menos un derivado de estrobirulina; agentes que las comprenden; procedimiento para combatir hongos fitopatogenos en fitoproteccion; y uso de las combinaciones.
BR112013003530A2 (pt) ''produto farmacêutico, kit, uso e preparações''
BRPI0814119A2 (pt) Método de análise de diafragma e uso dos produtos obtidos de acordo com o método
NI201400065A (es) Preparaciones que comprenden emodépsido amorfo
CL2012003080A1 (es) Compuestos derivados de alcoholes terciarios de dimetilciclohexilo, que emanan una nota de madera; composicion perfumada que los comprende; y su uso para la preparacion de una composicion tradicional de perfume, una composicion cosmetica, un producto de limpieza, entre otras.
NI201000212A (es) Dronedarona para la prevención de la cardioversión.
WO2015028745A3 (fr) Composition cosmétique comprenant un polymère sulfonique, un polysaccharide hydrophobe et un tensioactif siliconé
FR2984735B1 (fr) Composition hydratante
ITPD20060092A1 (it) Prodotto cosmetico o farmaceutico per uso topico
ITRM20050308A1 (it) Metodo per incrementare la sopravvivenza di ceppi batterici del genere rhizobium.
ITTO20060918A1 (it) Composizione cosmetica e farmaceutica e mezzo di coltura per la rigenerazione del tessuto cutaneo, e relativi usi
RU2007149424A (ru) Средство для защиты от биоповреждений промышленных материалов, изделий и древесины
FR2940618B1 (fr) Nouvel extrait d'acanthe, son procede de preparation et son utilisation dans une composition cosmetique capillaire.
ES2426017B1 (es) Microemulsión que comprende colagenasa y usos
ES2427429B1 (es) Composición cosmética para el tratamiento de cabello
BRPI0910058A2 (pt) agentes adrenérgicos alfa 2 de subtipo seletivo e métodos para uso dos mesmos